St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke – MarketWatch


"The Street" is certainly on the pulse of PFO as you may already be aware.  They were first to report.  But what does it mean??  Be careful not to just follow St. Jude stock today.  Here's the early MarketWatch Report: http://www.marketwatch.com/story/st-jude-medical-respect-trial-for-pfo-closure-provides-clinical-evidence-of-risk-reduction-in-prevention-of-recurrent-cryptogenic-stroke-2012-10-25  

Advertisements

PFO Patients, be cautious what to EXPECT from RESPECT Clinical Trial


The PFO chatter around TCT may indeed be a bit more popular this week than in previous years, but RESPECT will only get PFO closure back to "base camp" at best if the results show promise. -DP Dansereau, Know-Stroke.org I am remided of the "base camp" reference made for PFO closure that stuck in my …

PFO-Research-Foundation Patient Survey for 2012


Attention PFO Patients: Please Take our 2012 Patient Survey We're conducting our second PFO-Research-Foundation-Survey for PFO Patients. This survey is only for patients diagnosed with patent foramen ovale (PFO). If you have a PFO your answers to this survey could help other patients and the medical community alike to understand how PFO’s are being diagnosed …

What is the most frequent source of cardioembolic stroke in young adults?


This question (and the answer below) appeared in today's Resident e-Bulletin / Teaching Topics from the New England Journal of Medicine Patent foramen ovale (PFO) is the most frequent cardioembolic risk factor for stroke in young adults. Others include congenital heart disease, infectious nonbacterial thrombotic endocarditis, rheumatic valvular heart disease, cardiac surgery or catheter intervention, …